VAT implications of pharmaceutical rebates – Boehringer Ingelheim Ltd v HMRC
Menzies
MAY 21, 2025
Menzies LLP - A leading chartered accountancy firm. Implications for pharmaceutical suppliers This decision has broader implications for pharmaceutical companies supplying branded medicines to the NHS, particularly those participating in similar price control schemes.
Let's personalize your content